RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135

Benzinga · 1d ago
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.